Scott Garrett has more than 35 years of experience leading global healthcare businesses with emphasis in diagnostics, life sciences, medical products, specialty distribution and laboratory services. He has completed more than 40 mergers and acquisitions over the course of his career building substantial shareholder value. Scott most recently served as chairman, president & chief executive officer of Beckman Coulter, Inc., a multi-billion dollar business listed on the NYSE for over 50 years. He led the company through an eight-year period of growth and value creation establishing it as a leader in biomedical testing. Scott began his career in R&D at Baxter International, where his career progressed through several senior staff and general management positions before being appointed group vice president and CEO of Baxter’s global laboratory products subsidiary. He led the buyout of that business, becoming chairman, president and CEO of Dade Behring, Inc. Scott and his team built Dade Behring into one of the world’s largest clinical diagnostics companies. Prior to Beckman, Scott founded Garrett Capital Advisors and partnered with members of the Water Street team to build a group of private companies in the medical device and life science industries. Scott is an active member of the Advanced Medical Technology Association (AdvaMed). He has a combined tenure of 10 years on AdvaMed’s board of directors and was instrumental in founding AdvaMed Dx, an industry association focused on in vitro diagnostics. Scott serves as chairman of MarketLab and Orgentec. He is a director of Immucor, Inc. and Hologic, Inc. He also donates his time as a director for Genesys Works, a non-profit organization dedicated to the advancement of inner city high school students. Scott received a bachelor’s degree in engineering from Valparaiso University and a master’s degree in business administration from Lake Forest Graduate School of Management. He also completed the Executive Program at Stanford University Graduate School of Business.